Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Anika Therapeutics (ANIK)

Anika Therapeutics (ANIK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 516,807
  • Shares Outstanding, K 14,198
  • Annual Sales, $ 114,610 K
  • Annual Income, $ 27,190 K
  • 60-Month Beta 1.18
  • Price/Sales 4.61
  • Price/Cash Flow 14.81
  • Price/Book 1.80

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.13
  • Number of Estimates 1
  • High Estimate 0.13
  • Low Estimate 0.13
  • Prior Year 0.64
  • Growth Rate Est. (year over year) -79.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.16 +4.98%
on 07/09/20
39.54 -9.32%
on 07/06/20
-2.51 (-6.54%)
since 07/02/20
3-Month
27.53 +30.23%
on 05/14/20
39.70 -9.68%
on 07/02/20
+3.55 (+10.99%)
since 05/01/20
52-Week
22.01 +62.93%
on 03/19/20
75.71 -52.64%
on 10/25/19
-19.12 (-34.78%)
since 08/02/19

Most Recent Stories

More News
Anika Therapeutics (ANIK) Q2 Earnings and Revenues Surpass Estimates

Anika (ANIK) delivered earnings and revenue surprises of 142.86% and 83.37%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

ANIK : 35.91 (-1.35%)
Anika: 2Q Earnings Snapshot

BEDFORD, Mass. (AP) _ Anika Therapeutics Inc. (ANIK) on Thursday reported a second-quarter loss of $7.7 million, after reporting a profit in the same period a year earlier.

ANIK : 35.91 (-1.35%)
Anika To Launch Six FDA-Cleared Sports Medicine and Extremities Products in Third Quarter of 2020

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with products across the orthopedic early intervention continuum of care,...

ANIK : 35.91 (-1.35%)
Facial Aesthetics Market Revenue to Record Stellar Growth Rate During 2018 - 2026

Facial aesthetics are non-surgical treatments which revitalize the skin. Facial aesthetics are brisk and simple and far less expensive. It's a decent initial step for women to adopt wider range of medical...

AGN : 193.02 (+0.02%)
ANIK : 35.91 (-1.35%)
NVS : 84.20 (+2.51%)
VRX.TO : 30.80 (-3.33%)
Anika to Issue Second Quarter 2020 Financial Results and Business Highlights on Thursday, July 30

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with products across the orthopedic early intervention continuum of care,...

ANIK : 35.91 (-1.35%)
Global Collagen and HA-Based Biomaterials Industry

, /PRNewswire/ --Global Collagen and HA-Based Biomaterials Market to Reach by the Year 2027 Amid the COVID-19 crisis, the global market for Collagen and HA-Based Biomaterials estimated at in the year...

AGN : 193.02 (+0.02%)
ANIK : 35.91 (-1.35%)
MFAC : 10.48 (unch)
SKUNF : 16.0000 (unch)
TINLY : 14.1400 (-2.95%)
Neuronetics Announces Appointment of Bruce J. Shook to its Board of Directors

Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric...

ANIK : 35.91 (-1.35%)
STIM : 2.79 (+4.49%)
Global Facial Aesthetics Market 2020 Industry Outlook, Key Players, Segmentation Analysis, Business Growth and Forecast to 2026

The recently added market research study presents a detailed assessment of the market and display market sizing trend by revenue & volume, current growth factors, expert opinions, facts, and industry-validated...

ANIK : 35.91 (-1.35%)
VRX.TO : 30.80 (-3.33%)
Global Cartilage Repair/Regeneration Market Analysis and Forecasts to 2025, with Key Players Profiles Including Anika Therapeutics, Inc., Arthrex, Inc, DePuy Synthes and Zimmer Biomet - ResearchAndMarkets.com

The "Cartilage Repair/Regeneration Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

ANIK : 35.91 (-1.35%)
Cosmetic Surgery Market May Set New Growth Story | Allergan, Mentor Worldwide, Galderma

HTF MI Analyst have added a new research study on Title with detailed information of Product Types [, Surgical Procedure & Non-surgical Procedure], Applications [Hospitals, Dermatology clinics & Others]...

AGN : 193.02 (+0.02%)
ANIK : 35.91 (-1.35%)
HOLX : 71.05 (+1.82%)
ELOS : 11.00 (unch)
VRX.TO : 30.80 (-3.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade ANIK with:

Business Summary

Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative...

See More

Key Turning Points

2nd Resistance Point 38.91
1st Resistance Point 37.66
Last Price 35.91
1st Support Level 35.24
2nd Support Level 34.07

See More

52-Week High 75.71
Fibonacci 61.8% 55.20
Fibonacci 50% 48.86
Fibonacci 38.2% 42.53
Last Price 35.91
52-Week Low 22.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar